main content start

Pagina inicial

Continue Watching

Últimos vídeos

Últimos vídeos

Brightcove Home Latest Listing

Oncology

Oncology

Brightcove Cards Listing

Hematology

Hematology

Brightcove Cards Listing

Popular em MedEnrich

Popular em MedEnrich

Popular in Sem nome
  • Myelodysplastic Syndromes23m 43s

    Desenvolvimento e Atualizações na Biologia das Mielodisplasias

    Desenvolvimento e Atualizações na Biologia das Mielodisplasias (MDS)
    síndromes mielodisplásicas mds avanços na biologia terapias inovadoras epidemiologia da mds
  • Oncospecials15m 30s

    A Relevância dos Agentes TKI na era das imunoterapias para o tratamento do carcinoma de células Renais

    ONCOPLUS apresenta: vídeo-aula com Dr. Denis Jardim na patologia de carcinoma de células renais.
    oncologia ccr câncer renal tki sunitinibe
  • Mieloma múltiplo9m 20s

    Integrating Pomalidomide Based Regimens in Multiple Myeloma

    Integrating pomalidomide and dexamethasone in the treatment of relapsed or refractory multiple myeloma (RRMM) involves using them as a core regimen, often combined with other agents like bortezomib or monoclonal antibodies for enhanced efficacy.
    pomalidomide-dexamethasone rrmm management progression-free survival combination therapies
  • Câncer de próstata6m 59s

    Managing Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC)

    3 randomized clinical trials (SPRATAN- Apalutamide), (PROSPER -Enzalutamide) & (ARAMIS -Darolutamide) have shown consistent and almost similar benefit in Metastasis Free Survival in nmCRPC
    nmcrpc metastasis free survival spartan prosper & aramis clinical trial
  • Myelodysplastic Syndromes14m 13s

    ASH 2022 Update on Myelodysplastic Syndromes

    ASH 2022 - Update on Myelodysplastic Syndromes
    low risk mds venetoclax viale -a eln classification low dose lenalidomide tags: azacitidine
  • Mieloma múltiplo17m 14s

    Tratamento do mieloma múltiplo

    Tratamento do mieloma multiplo_Dr Ederson Mattos
    mm mieloma múltiplo tratamento lenalidomida nccn ederson mattos
  • Acute Myeloid Leukaemia12m 22s

    EHA 2022 Updates : AML

    EHA Updates AML : QuANTUM phase 3 study showed significant overall survival in adults having FLT3-ITD+ acute myeloid leukaemia with  addition of quizartinib to standard induction and consolidation therapy alone.
    aml decitabine g-csf hypomethylating agents
  • nasopharyngeal carcinoma44m 35s

    Comprehensive Overview of Nasopharyngeal Carcinoma

    Over the last few years treatment of Nasopharyngeal Carcinoma has evolved with minimally invasive surgery, advances in chemotherapy & immunotherapy.
    nasopharyngeal carcinoma immunotherapy
  • 14m 46s

    ESMO 2022 Breast Cancer Comprehensive Coverage

    View comprehensive coverage of Breast Cancer from ESMO 2022
    dose dense adjuvant chemotherapy esmo keynote -522 monarch -3 study
  • Oncospecials14m 58s

    Is TKI Monotherapy still relevant for advanced Renal Cell carcinoma

    ICIs in combination with VEGF-targeted treatments have become standard of care in 1st line advanced RCC ,however there are certain group of patients wherein treatment with single agent TKI can still be considered optimal
    1st line rcc single agent tki
  • Webinar passado

    Webinar Cards Listing

    MedBytes

    MedBytes

    Medbytes Cards Listing
    Hola, ¿puedo ayudar?
    Suporte por bate-papoX
    Equipe de suporte
    Hola, ¿cómo puedo ayudarlo hoy?
    Seleccione una de las siguientes opciones.

    Buscar información

    No puedo iniciar sesión o registrarse

    compartilhar comentarios